omniture
PILATUS BIOSCIENCES

Latest News

Pilatus Biosciences to Present Research on PLT012 at AACR 2025

Novel Immunometabolism Approach Targets Immune-Cold Solid Tumors DOVER, Del. and EPALINGES, Switze...

2025-04-15 20:35 1688

Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment

DOVER, Del. and EPALINGES, Switzerland, Dec. 10, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. anno...

2024-12-11 11:04 1713